Roux, C <br/><br/>
Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Jan 2012 
 - 277-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-011-1574-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--adverse effects<br/>Etidronic Acid--adverse effects<br/>Female<br/>Femur Neck--physiopathology<br/>Gastrointestinal Diseases--chemically induced<br/>Humans<br/>Lumbar Vertebrae--physiopathology<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--complications<br/>Osteoporotic Fractures--prevention & control<br/>Polypharmacy<br/>Proton Pump Inhibitors--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Risedronic Acid<br/>Spinal Fractures--etiology<br/>Treatment Outcome